Brachytherapy Market Size-By Product, By Dosage Type, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Description

Global Brachytherapy Market Overview

According to SPER Market Research, the Global Brachytherapy Market is estimated to reach USD 1.84 billion by 2032 with a CAGR of 7.33%.

Brachytherapy equipment is recommended over other radiation therapy equipment for cancer therapy because patients treated with this equipment have a low chance of experiencing a future relapse. Image Guided Brachytherapy (IGBT) and Pulse Dose Rate are two other contemporary brachytherapy techniques (PDR). Brachytherapy is currently enabled by programming agreements that enable the providers of medical services to legally provide and schedule brachytherapy for patients. In the previous years, the prostate cancer market was anticipated to dominate and account for the largest income share. Brachytherapy is a viable treatment option for all individuals with confined prostate cancer development, both when used alone and in conjunction with outer bar radiation therapy. The category is being driven by the promising applications of brachytherapy in the treatment of prostate cancer. During the projection period, a significant CAGR is anticipated for the breast cancer brachytherapy application segment. One of the main factors propelling the development of this market is the growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI). Additionally, the growing incidence of breast cancer is anticipated to fuel the growth of this market.

Impact of COVID-19 on the Global Brachytherapy Market

Global healthcare systems have been impacted by the COVID-19 epidemic, and the market for brachytherapy equipment has also been significantly impacted. According to last year study titled "The Impact of COVID-19 on Brachytherapy," Advances in radiation oncology allowed six patients with unfavourable intermediate- and high-risk diseases to elect to receive EBRT followed by a brachytherapy boost, and since elective surgeries had to be postponed within the system due to the pandemic, four patients were treated with brachytherapy instead. The majority of cancer patients were safely treated with just minimal treatment delays and disruptions, despite the difficulties the healthcare system experienced throughout the epidemic. Therefore, they were considerably impacted as a result of the restrictions imposed by COVID-19. However, the need for brachytherapy equipment is anticipated to increase due to the rise in cardiac procedures.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2032

Base year considered 2021

Forecast period 2022-2032

Segments covered By Product, By Dosage Type, By End User, By Application.

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered Argon Medical Devices, Becton, Best Vascular, Carl Zeiss Meditec AG, CIVCO MEDICAL SOLUTIONS, Dickinson and Company, Eckert & Zieglet BEBIG A.G, Elekta AB, iCAD Inc, Isoray Inc, Panacea Medical Technology Pvt. Ltd., RadiaDyne, SUN NUCLEAR CORPORATION, Theragenics Corporation, VARIAN MEDICAL SYSTEMS, Inc.

Global Brachytherapy Market Segmentation:

By Product: Based on the Type, Global Brachytherapy Market is segmented as; (Applicators & Afterloaders, Electronic Brachytherapy, Seeds)

By Dosage: Based on the Dosage, Global Brachytherapy Market is segmented as;(High-Dose Rate (HDR)Brachytherapy, Low-Dose Rate (LDR)Brachytherapy)

By End User: Based on the End User, Global Brachytherapy Market is segmented as; (Hospitals, Specialty Clinics, Others)

By Application: Based on the Application, Global Brachytherapy Market is segmented as; (Breast Cancer, Gynecological Cancer, Prostate Cancer, Others)

By Region: The regions of Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa make up the worldwide market. Due to the significant presence of major international players and the widespread use of cutting-edge brachytherapy technologies by healthcare facilities in the region, North America is anticipated to dominate the market during the forecast period.

Product Code: HLCA2312

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Brachytherapy Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Competitive Landscape

6.1 Global Brachytherapy Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Brachytherapy Market

7. Global Brachytherapy Market, By Product, 2019-2032 (USD Million)

7.1 Applicators & Afterloaders
7.2 Electronic Brachytherapy
7.3 Seeds

8. Global Brachytherapy Market, By Dosage Type, 2019-2032 (USD Million)

8.1 High-Dose Rate (HDR)Brachytherapy
8.2 Low-Dose Rate (LDR)Brachytherapy

9. Global Brachytherapy Market, By Application, 2019-2032 (USD Million)

9.1 Breast Cancer
9.2 Gynecological Cancer
9.3 Prostate Cancer
9.4 Others

10. Global Brachytherapy Market, By End-User, 2019-2032 (USD Million)

10.1 Hospitals
10.2 Specialty Clinics
10.3 Others

11. Global Brachytherapy Market, By Region, 2019-2032 (USD Million)

11.1 Global Brachytherapy Market Size and Market Share by Region (2019-2025)
11.2 Global Brachytherapy Market Size and Market Share by Region (2026-2032)
11.3 Asia-Pacific
- 11.3.1 Australia
- 11.3.2 China
- 11.3.3 India
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 Rest of Asia-Pacific
11.4 Europe
- 11.4.1 France
- 11.4.2 Germany
- 11.4.3 Italy
- 11.4.4 Spain
- 11.4.5 United Kingdom
- 11.4.6 Rest of Europe
11.5 Middle East and Africa
- 11.5.1 Kingdom of Saudi Arabia
- 11.5.2 United Arab Emirates
- 11.5.3 Rest of Middle East & Africa
11.6 North America
- 11.6.1 Canada
- 11.6.2 Mexico
- 11.6.3 United States
11.7 Latin America
- 11.7.1 Argentina
- 11.7.2 Brazil
- 11.7.3 Rest of Latin America

12.Company Profiles

12.1 Argon Medical Devices
- 12.1.1 Company details
- 12.1.2 Financial outlook
- 12.1.3 Product summary
- 12.1.4 Recent developments
12.2 Becton
- 12.2.1 Company details
- 12.2.2 Financial outlook
- 12.2.3 Product summary
- 12.2.4 Recent developments
12.3 Best Vascular, Inc
- 12.3.1 Company details
- 12.3.2 Financial outlook
- 12.3.3 Product summary
- 12.3.4 Recent developments
12.4 Carl Zeiss Meditec AG
- 12.4.1 Company details
- 12.4.2 Financial outlook
- 12.4.3 Product summary
- 12.4.4 Recent developments
12.5 CIVCO MEDICAL SOLUTIONS
- 12.5.1 Company details
- 12.5.2 Financial outlook
- 12.5.3 Product summary
- 12.5.4 Recent developments
12.6 Dickinson and Company
- 12.6.1 Company details
- 12.6.2 Financial outlook
- 12.6.3 Product summary
- 12.6.4 Recent developments
12.7 Eckert & Ziegler BEBIG S.A
- 12.7.1 Company details
- 12.7.2 Financial outlook
- 12.7.3 Product summary
- 12.7.4 Recent developments
12.8 Elekta AB.
- 12.8.1 Company details
- 12.8.2 Financial outlook
- 12.8.3 Product summary
- 12.8.4 Recent developments
12.9 iCAD Inc
- 12.9.1 Company details
- 12.9.2 Financial outlook
- 12.9.3 Product summary
- 12.9.4 Recent developments
12.10 Isoray Inc
- 12.10.1 Company details
- 12.10.2 Financial outlook
- 12.10.3 Product summary
- 12.10.4 Recent developments
12.11 Panacea Medical Technology Pvt. Ltd.
- 12.11.1 Company details
- 12.11.2 Financial outlook
- 12.11.3 Product summary
- 12.11.4 Recent developments
12.12 RadiaDyne
- 12.12.1 Company details
- 12.12.2 Financial outlook
- 12.12.3 Product summary
- 12.12.4 Recent developments
12.13 SUN NUCLEAR CORPORATION
- 12.13.1 Company details
- 12.13.2 Financial outlook
- 12.13.3 Product summary
- 12.13.4 Recent developments
12.14 Theragenics Corporation
- 12.14.1 Company details
- 12.14.2 Financial outlook
- 12.14.3 Product summary
- 12.14.4 Recent developments
12.15 VARIAN MEDICAL SYSTEMS, INC.
- 12.15.1 Company details
- 12.15.2 Financial outlook
- 12.15.3 Product summary
- 12.15.4 Recent developments